All signals GO! Leipzig has launched construction on its centrally-located Innovation Center which is slated to open in 2026.
Green light for biotechnology – Leipzig’s new Innovation Center


All signals GO! Leipzig has launched construction on its centrally-located Innovation Center which is slated to open in 2026.

After just receiving almost 2 million dollars in funding to establish a digital ‘vaccine library’, Leipzig University’s Institute for Drug Development is celebrating its next windfall.

digital-health
Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers
Upcoming viral threats need a fast response to prevent future pandemics. That’s why Leipzig University is now establishing a digital ‘vaccine library’ so that researchers and clinicians can quickly develop effective vaccines in these situations.

Preclinical and clinical development of a novel CAR-T cell therapy for the treatment of multiple myeloma and clear cell renal cell carcinoma.

Universitätsklinikum Leipzig
© Universitätsklinikum Leipzig
Imagine that a top surgeon could help operate on you from 100 km away. Science fiction? Not in Leipzig!

Think ‘Shark Tank’ for the medical industry: #kiddingnotkidding.

As a renter, you want a flexible setup and good neighbors. That’s why future life science industry tenants of CCL CityLab Leipzig can count themselves lucky

Children’s hospice Bärenherz Leipzig e.V. relies on external funds to help kids and their families.

As co-hosts, we are proud to share that the biotech partnering event BIO-Europe 2022 broke all records. We welcomed more than 5,000 guests from 66 countries here in Leipzig! Were you there to see us make the leap into the Champions League of life science locations in Europe? Click below to enjoy our gallery of pictures from the event.

cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications